Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Faisal Ghiath Sukhtian currently holds 19,771 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Faisal Ghiath Sukhtian has been a net buyer of OTLK stock. They have purchased $88.8K and sold $0 worth of shares.
Faisal Ghiath Sukhtian's most recent insider trade was on Oct 3, 2024, when they sold 19,771 shares at $0.00 per share.
Faisal Ghiath Sukhtian serves as Executive at Outlook Therapeutics, Inc. (OTLK). They have executed 9 insider transactions totaling $88.8K over their tenure at the company.
Faisal Ghiath Sukhtian holds the position of Executive at Outlook Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Faisal Ghiath Sukhtian has shown a buying trading pattern, with $88.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Faisal Ghiath Sukhtian was on Feb 1, 2019, when they purchased $4.0M worth of OTLK shares. This transaction involved 4,288,624 shares at $0.93 per share.
Faisal Ghiath Sukhtian currently owns 19,771 shares of Outlook Therapeutics, Inc. (OTLK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Faisal Ghiath Sukhtian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Faisal Ghiath Sukhtian has 9 Form 4 filings on record as an insider at Outlook Therapeutics, Inc..
Set alerts for Faisal Ghiath Sukhtian and 40,000+ other insiders.